2021
DOI: 10.1016/j.pan.2020.12.012
|View full text |Cite
|
Sign up to set email alerts
|

Endoscopic ultrasound elastography for small solid pancreatic lesions with or without main pancreatic duct dilatation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 40 publications
0
8
0
2
Order By: Relevance
“…Für die Differenzierung zwischen benignen und malignen Pankreasraumforderungen kann die EUS-Elastografie hilfreich sein. Zum einen weist die EUS-Elastografie eine sehr gute Sensitivität auf und zum anderen hat sie einen hohen negativen Prädiktionswert [66,67]. Die PK-Verdachtsdiagnose weiter erhärten kann schließlich die Kontrastmittelgabe (CE-EUS) [68].…”
Section: Endosonografie Und Pk-früherkennungunclassified
“…Für die Differenzierung zwischen benignen und malignen Pankreasraumforderungen kann die EUS-Elastografie hilfreich sein. Zum einen weist die EUS-Elastografie eine sehr gute Sensitivität auf und zum anderen hat sie einen hohen negativen Prädiktionswert [66,67]. Die PK-Verdachtsdiagnose weiter erhärten kann schließlich die Kontrastmittelgabe (CE-EUS) [68].…”
Section: Endosonografie Und Pk-früherkennungunclassified
“…The technique does not increase operation time or risk of adverse effects on evaluation [78]. Endoscopic ultrasound elastography has also been used in the identification of pancreatic duct dilatation that correlated with higher stiffness index and head-based locations in patients with pancreatic cancer [77]. The elastic modulus as shown by elastography is also useful in appendicitis and other infections.…”
Section: Use In Gastrointestinal Tissuesmentioning
confidence: 99%
“…Currently, there are seven meta-analyses (Table 1) [31][32][33][34][35][36][37] that include strain EUS-E for pancreatic cancer and showed a specificity of 92-98% and a specificity of 67-76%. However, two studies assessed small pancreatic tumors of less than 15 and 20 mm, respectively, and pointed out that EUS-E might be confident in suggesting that PDAC is a stiff tumor [38,39]. Kataoka et al [38] analyzed 126 cases of small pancreatic lesions associated or not with main pancreatic duct dilation.…”
Section: Pancreatic Massesmentioning
confidence: 99%
“…However, two studies assessed small pancreatic tumors of less than 15 and 20 mm, respectively, and pointed out that EUS-E might be confident in suggesting that PDAC is a stiff tumor [38,39]. Kataoka et al [38] analyzed 126 cases of small pancreatic lesions associated or not with main pancreatic duct dilation. They concluded that a stiffness ratio was definitely higher for pancreatic cancer 62:3 vs. 29:32, P < 0.001.…”
Section: Pancreatic Massesmentioning
confidence: 99%